SONNET BIOTHERAPEUTICS HOLDI (SONN) Stock Income Statement
NASDAQ:SONN - Nasdaq - US83548R4020 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-9-30) | 2023 (2023-9-30) | 2022 (2022-9-30) | 2021 (2021-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.00M | 18.60K | 147.80K | 350.00K | 480.00K | |||
| Minority Interest Expense | N/A | N/A | N/A | N/A | N/A | |||
| Cost Of Goods | N/A | N/A | N/A | N/A | N/A | |||
| Gross Profit | N/A | N/A | N/A | N/A | N/A | |||
| Operating Expenses | 14.78M | 11.87M | 18.94M | 30.02M | 25.57M | |||
| Research and Development | 6.70M | 5.74M | 11.81M | 21.44M | 16.63M | |||
| Selling, General, and Administrative Expenses | 8.08M | 6.13M | 7.13M | 8.58M | 8.94M | |||
| Operating Income | -13.78M | -11.85M | -18.79M | -29.67M | -25.09M | |||
| Interest Income/Expense | -66.80K | 84.30K | -40.10K | -50.00K | -20.00K | |||
| Other Income/Expense | N/A | 28.00K | N/A | 0.00 | 130.00K | |||
| Non Recurring Items | N/A | 4.30M | N/A | N/A | 0.00 | |||
| Income Before Taxes | -13.13M | -7.44M | -18.83M | -29.72M | -24.98M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -13.29M | -7.44M | -18.83M | -29.72M | -24.98M | |||
| EBITDA | -13.66M | -11.77M | -18.72M | -29.66M | -25.08M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -11.35 | -11.35 | -145.12 | -148.60 | -312.25 | |||
| Non GAAP EPS | -11.88 | -11.35 | -240.24 | -1.21K | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Profit Margin | -1328.60% | -39984.95% | -12742.02% | -8491.43% | -5204.17% | |||
| Operating Profit Margin | -1378.09% | -63706.99% | -12714.88% | -8477.14% | -5227.08% | |||
All data in USD